Medtronic plc — Director's Dealing 2023

Aug 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2023-08-03

Reporting Person: PARKHILL KAREN L (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-03	Ordinary Shares	A	7105	—	Acquired	52246	Direct
2023-08-03	Ordinary Shares	F	5919	$84.49	Disposed	46327	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-03	Performance Share Units	$	M	7105	Disposed		Performance Share Units (7105)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	49859	Indirect
Ordinary Shares	843	Indirect
Ordinary Shares	843	Indirect
Ordinary Shares	843	Indirect

Footnotes

F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents.

F2: Includes 723 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1.

F3: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023.

F4: These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.

F5: Each performance share unit represented a contingent right to receive one share of Medtronic common stock.

F6: The performance share units vested on August 3, 2023.